These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12409165

  • 1. Depressive symptoms at baseline predict fewer negative symptoms at follow-up in patients with first-episode schizophrenia.
    Oosthuizen P, Emsley RA, Roberts MC, Turner J, Keyter L, Keyter N, Torreman M.
    Schizophr Res; 2002 Dec 01; 58(2-3):247-52. PubMed ID: 12409165
    [Abstract] [Full Text] [Related]

  • 2. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
    Riedel M, Mayr A, Seemüller F, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Schennach-Wolff R.
    World J Biol Psychiatry; 2012 Jan 01; 13(1):30-8. PubMed ID: 21568628
    [Abstract] [Full Text] [Related]

  • 3. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.
    Marder SR, Davis JM, Chouinard G.
    J Clin Psychiatry; 1997 Dec 01; 58(12):538-46. PubMed ID: 9448657
    [Abstract] [Full Text] [Related]

  • 4. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W.
    Int J Neuropsychopharmacol; 2008 Nov 01; 11(7):985-97. PubMed ID: 18466670
    [Abstract] [Full Text] [Related]

  • 5. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
    Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.
    J Clin Psychiatry; 2006 Oct 01; 67(10):1511-21. PubMed ID: 17107241
    [Abstract] [Full Text] [Related]

  • 6. Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
    Usall J, López-Carrilero R, Iniesta R, Roca M, Caballero M, Rodriguez-Jimenez R, Oliveira C, Bernardo M, Corripio I, Sindreu SD, González Piqueras JC, Felipe AE, Fernandez de Corres B, Ibáñez A, Huerta R, Abordaje Síntomas Negativos Esquizofrenia Group.
    J Clin Psychiatry; 2014 Jun 01; 75(6):608-15. PubMed ID: 25004184
    [Abstract] [Full Text] [Related]

  • 7. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD, Rabinowitz J, Eerdekens M, Davidson M.
    Am J Psychiatry; 2005 Oct 01; 162(10):1888-95. PubMed ID: 16199835
    [Abstract] [Full Text] [Related]

  • 8. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
    Tollefson GD, Andersen SW.
    J Clin Psychiatry; 1999 Oct 01; 60 Suppl 5():23-9; discussion 30. PubMed ID: 10192404
    [Abstract] [Full Text] [Related]

  • 9. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec 01; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 10. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
    Feldman PD, Kaiser CJ, Kennedy JS, Sutton VK, Tran PV, Tollefson GD, Zhang F, Breier A.
    J Clin Psychiatry; 2003 Sep 01; 64(9):998-1004. PubMed ID: 14628974
    [Abstract] [Full Text] [Related]

  • 11. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.
    Emsley RA, Oosthuizen PP, Joubert AF, Roberts MC, Stein DJ.
    J Clin Psychiatry; 1999 Nov 01; 60(11):747-51. PubMed ID: 10584762
    [Abstract] [Full Text] [Related]

  • 12. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
    Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M.
    J Clin Psychiatry; 2004 Apr 01; 65(4):551-6. PubMed ID: 15119920
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE, Pantelis C, Dineen M, Benattia I, Romano SJ.
    J Clin Psychiatry; 2004 Dec 01; 65(12):1624-33. PubMed ID: 15641867
    [Abstract] [Full Text] [Related]

  • 14. The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone.
    Tollefson GD, Andersen SW, Tran PV.
    Biol Psychiatry; 1999 Aug 01; 46(3):365-73. PubMed ID: 10435202
    [Abstract] [Full Text] [Related]

  • 15. Trajectories and antecedents of treatment response over time in early-episode psychosis.
    Levine SZ, Rabinowitz J.
    Schizophr Bull; 2010 May 01; 36(3):624-32. PubMed ID: 18849294
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP, Khan A, Iskander A, Abad MT, Parker B.
    J Clin Psychiatry; 2007 Mar 01; 68(3):368-79. PubMed ID: 17388705
    [Abstract] [Full Text] [Related]

  • 17. The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.
    Janicak PG, Glick ID, Marder SR, Crandall DT, McQuade RD, Marcus RN, Eudicone JM, Assunção-Talbott S.
    J Clin Psychiatry; 2009 Jan 01; 70(1):25-35. PubMed ID: 19192472
    [Abstract] [Full Text] [Related]

  • 18. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van Hove I, Eerdekens M, Swyzen W, De Smedt G, Early Psychosis Global Working Group.
    Am J Psychiatry; 2005 May 01; 162(5):947-53. PubMed ID: 15863797
    [Abstract] [Full Text] [Related]

  • 19. Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates.
    Emsley R, Rabinowitz J, Medori R, Early Psychosis Global Working Group.
    Schizophr Res; 2007 Jan 01; 89(1-3):129-39. PubMed ID: 17095194
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X, Savage R, Borisov A, Rosenberg J, Woolwine B, Tucker M, May R, Feldman J, Nemeroff CB, Miller AH.
    J Psychiatr Res; 2006 Oct 01; 40(7):669-76. PubMed ID: 16762371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.